White House Chief of Staff Susie Wiles Reveals Early-Stage Breast Cancer Diagnosis

White House Chief of Staff Susie Wiles, 68, disclosed on Monday that she has been diagnosed with early-stage breast cancer after a routine mammography screening detected a small tumor in her left breast. Wiles, widely regarded as the most powerful woman in Washington and the first female chief of staff in history, said she intends to remain in her position while undergoing treatment.

President Trump released a statement calling Wiles "the toughest person I know" and expressing full confidence in her ability to continue leading the West Wing. "Susie is a warrior. She's been fighting for this country every single day, and she's going to beat this too," the President said. Wiles's oncologist at Walter Reed National Military Medical Center confirmed the cancer was caught at Stage I and that her prognosis is favorable.

The diagnosis comes at one of the most turbulent periods in recent White House history. Wiles has been the administration's operational linchpin, coordinating the U.S. military response to Iran, managing fallout from the partial government shutdown now in its third week, and shepherding the SAVE America Act through Congress. Senior aides told reporters that she was back on calls within hours of her initial consultation.

Wiles plans to undergo a lumpectomy followed by a course of radiation therapy over the coming weeks. She told staff in an internal memo that she would work remotely on treatment days but otherwise maintain her normal schedule, which typically begins before 6 a.m. and extends well past midnight. Deputy Chief of Staff Stephen Miller will serve as her operational backup on days she is unavailable.

The announcement drew bipartisan well-wishes from Capitol Hill. Senate Majority Leader John Thune and Minority Leader Chuck Schumer both released statements praising Wiles's dedication. Former chiefs of staff from both parties, including James Baker and Denis McDonough, reached out privately to offer support.

Breast cancer affects roughly one in eight American women over their lifetimes, according to the American Cancer Society. Early-stage diagnoses like Wiles's carry a five-year survival rate above 99 percent. Her public disclosure was praised by cancer advocacy groups, who said her visibility could encourage more women to keep up with regular screenings during a period when preventive care appointments have declined nationally by 12 percent since the pandemic.